This webinar will examine the existing and proposed requirements for the U.S. FDA’s DHF, 21 CFR 820.30 and now ISO 13485:2016 7.3 including its derivative documents, the DMR and DHR. It will consider the European Union’s MDD TF/DD and its transition to the EU MDR requirements, and evaluate the documents’ differing purposes / goals, as well as the two different device classification schemes. Required and desirable contents will be discussed.

Also considered: Areas requiring frequent re-evaluation / update; Similarities and differences; Future trends; Typical DHF Table of Contents, Technical File or Design Dossier Table of Contents, The importance and usefulness of the “Essential Requirements”; Structure of the “Declaration of Conformity”,self-declaring or N-B reviewed; Parallel approaches to development. Finally, the differing approaches to file audits by the FDA and the Notified Body will be discussed.

Why You Should Attend:

One of our most popular webinars, now expanded to 3 hours, and continuously updated with the latest U.S. FDA and Eurpean Union requirements. As U.S. companies go global, they must meet different product design documentation. The cGMPs mandate Design Control and the Design History File (DHF).

In order to sell globally, the EU’s CE-marking documentation is a requirement the Technical FiIe or Design Dossier and now, Technical Documentation under the new EU MDR (Medical Device Regulation), which replaces the MDD (Medical Device Directive). Transitioning consideration / concerns.

The DHF / D&DP serve different purposes, support different goals, than the TF / DD / TD, but there are increasing similarities. And the DHF is adapting to some of the features of the TF/DD. And how / where do the DMR and DHR fit? Being aware of the similarities and differences in the files and their individual documents can further concurrent development and/or updates to both. Against the background of 21 CFR 820.30, ISO 13485:2016 7.3, and the transitioning from EU MDD to MDR.

Areas Covered in the Session :

The U.S. FDA’s 21 CFR 820.30 Design History File (DHF) and the ISO 13485:2016 Design and Development File

John E. Lincoln

John E. Lincoln, is Principal of J. E. Lincoln and Associates LLC, a consulting company with over 36 years experience in U.S. FDA-regulated industries, 22 of which are as an independent consultant. John has worked with companies from start-up to Fortune 100, in the U.S., Mexico, Canada, France, Germany, Sweden, China and Taiwan. He specializes in quality assurance, regulatory affairs, QMS problem remediation and FDA responses, new / changed product 510(k)s, process / product / equipment QMS and software validations, ISO 14971 product risk management files / reports, Design Control / Design History Files, Technical Files, CAPA systems and analysis.

He’s held positions in Manufacturing Engineering, QA, QAE, Regulatory Affairs, to the level of Director and VP (R&D). In addition, John has prior experience in military, government, electronics, and aerospace. He has published numerous articles in peer reviewed journals, conducted workshops and webinars worldwide on CAPA, 510(k)s, risk analysis / management, FDA / GMP audits, validation, root cause analysis, and others. He writes a recurring column for the Journal of Validation Technology. John is a graduate of UCLA.

Refund Policy

Webinar Compliance reserves the right to cancel or reschedule any Webinar/event due to inevitable reasons such as insufficient registrations or circumstances beyond its control. All the attendees will be notified about the cancellation of the event, 24 hours prior to the start time of the Webinar event.

The cancelled Webinar, could be rescheduled and a New Date would be promptly intimated to the attendees.

In such an event, the attendee can opt for one of the below :

If the New Date is not of convenience, the webinar stream (1-Time Recording) may be availed.

The attendees may also opt to take a different webinar, which has a same price tag at a future date & time; they are welcome to do so.

On-Demand recordings (Past events) in exchange but equal to the original amount remitted.

A redeemable voucher (Valid for 12 months), which could be used to purchase any of our future events.

Webinar Compliance will process refund only if an event that has been cancelled, is not rescheduled within 90 days from the original scheduled date of the webinar.

If a webinar is canceled completely, an attendee may opt either of above points 2,3,4, or a full refund of the amount paid in a single settlement. The payment will be processed within 7 Business days from the day, we receive the refund request. However, Webinar Compliance will not be responsible for any penalties or other expenditure incurred due to the cancellation.

​Individual attendees can cancel their event for any specific reason. They must notify Webinar Compliance about the cancellation of their registration at least 48 hours prior to the event start date and time.

If the attendee fails to cancel the registration to the event within the above mentioned stipulated time or if fails to attend the event, no refund shall be made.

​

​For further clarification on the refund or cancellation policy, you can contact the support team over the phone or please write to us on support@webinarcompliance.com, with the transaction ID, event ID & event date in the subject column.